openPR Logo
Press release

Biotage Introduces New SNAP XL Flash Purification Cartridges for Large Scale Separations

03-01-2011 03:53 PM CET | Science & Education

Press release from: Biotage

Biotage Introduces New SNAP XL Flash Purification Cartridges

Uppsala, Sweden, March 01, 2011 -- Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced 2 new additions to its SNAP XL family of cartridges for large scale and development purification. Released in both 750g and 1500g sizes, the new cartridges offer powerful solutions for reverse phase chromatography (KP-C18-HS) and also optimized silica for the separation of amines (KP-NH).

The 2 new cartridge sizes address a growing need for 100g+ scale purifications and offer chemists increased efficiency while reducing running costs. Additionally, the application of reverse phase flash chromatography and the separation of amines are growing trends in pharmaceutical drug development.

“There is growing market demand for large scale flash purification cartridges and we have collaborated with key customers to focus our product development efforts on pressing needs of chemists working in this area.” says Sunil Rana, Biotage product manager for flash purification “With the introduction of these new cartridges, Biotage now offers a solution for practically every scale-up situation.”

Alongside the industry leading KP-Sil cartridges for normal phase chromatography, these new SNAP XL cartridges further compliment Biotage's portfolio of flash chromatography solutions which offer seamless scalability from milligrams to 100+ grams. The overall SNAP cartridge line offers the widest range of options covering the chemist’s needs from the routine to highly specialized or complex separations.

For more information on the Biotage SNAP XL flash purification cartridges, please email product_info@biotage.com or visit www.biotage.com

-ENDS-

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 272 employees and had sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: http://www.biotage.com

For further press information at Biotage please contact:
Rob Thompson
Director of Marketing Communications
10430 Harris Oaks Blvd., Suite C,
Charlotte, NC USA 28269
Tel: +1 704 654 4847
Fax: +1 704 654 4917
Email: rob.thompson@biotage.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biotage Introduces New SNAP XL Flash Purification Cartridges for Large Scale Separations here

News-ID: 164538 • Views:

More Releases from Biotage

Biotage® Announces EVOLUTE® EXPRESS Columns - Simplified, Fast and Efficient SPE using the Load-Wash-Elute Procedure
Biotage® Announces EVOLUTE® EXPRESS Columns - Simplified, Fast and Efficient S …
Uppsala, Sweden -- Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, announces the addition of new polymer based SPE columns to their tried and tested EVOLUTE® EXPRESS range. EVOLUTE® EXPRESS is a novel family of plates, and now columns, that simplify polymer-based SPE by employing a streamlined three step protocol; Load-Wash-Elute. By using this approach and removing the conditioning and equilibration steps, necessary
Biotage Launches ACI™ - Accelerated Chromatographic Isolation
Biotage Launches ACI™ - Accelerated Chromatographic Isolation
Uppsala, Sweden (July 10, 2014) -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds. Biotage believes that ACI™ will radically improve the efficiency of the laboratory, embracing the latest developments in purification technology to guide chemists
Biotage Breaks New Ground with Its Fully Integrated Mass Directed Flash System
Biotage Breaks New Ground with Its Fully Integrated Mass Directed Flash System
Uppsala, Sweden, June 5, 2013 -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces the launch of the new Isolera™ Dalton - a fully automated miniaturized mass directed flash purification system. The new system raises the bar for flash purification by integrating, for the first time, a miniaturized mass detector and an advanced flash chromatography system into one commercially available

More Releases for SNAP

Lawsuit filed for Investors who lost money with shares of Snap Inc. (NYSE: SNAP)
An investor, who purchased shares of Snap Inc. (NYSE: SNAP), filed a lawsuit over alleged violations of Federal Securities Laws by Snap Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Snap Inc. (NYSE: SNAP) have certain options and for certain investors are short and strict deadlines running. Deadline: October 20, 2025. NYSE: SNAP investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Investors in Snap Inc. (NYSE: SNAP) over potential W …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Snap Inc. Investors who purchased shares of Snap Inc. (NYSE: SNAP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Snap Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Snap Inc. reported that
Investigation announced for Investors who lost money with shares of Snap Inc. (N …
An investigation was announced for investors of Snap Inc. (NYSE: SNAP) shares over potential securities laws violations by Snap Inc. Investors who purchased shares of Snap Inc. (NYSE: SNAP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Snap Inc. (NYSE: SNAP) concerning whether a series
Investigation announced for Long-Term Investors in Snap Inc. (NYSE: SNAP)
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Snap Inc.. Investors who are current long term investors in Snap Inc. (NYSE: SNAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: SNAP stocks follows a lawsuit filed against Snap Inc. over
Deadline on Jan. 10th coming up in Lawsuit for Investors in shares of Snap Inc. …
The Shareholders Foundation announced that a deadline is coming up on January 10, 2022 in the lawsuit filed for certain investors of Snap Inc. (NYSE: SNAP). Investors who purchased shares of Snap Inc. (NYSE: SNAP) have certain options and there are strict and short deadlines running. Deadline: January 10, 2022. NYSE: SNAP stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The plaintiff alleges on behalf
Lawsuit filed for Investors in shares of Snap Inc. (NYSE: SNAP) over alleged Sec …
An investor, who purchased shares of Snap Inc. (NYSE: SNAP), filed a lawsuit over alleged violations of Federal Securities Laws by Snap Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Snap Inc. (NYSE: SNAP) have certain options and for certain investors are short and strict deadlines running. Deadline: January 10, 2022. NYSE: SNAP investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call